Considering Toxicities and Side Effects of JAK Inhibitors in

Dr Jamile Shammo discusses how to approach sequencing therapies in patients with myelofibrosis and Dr Raajit Rampal explains the potential of the JAK inhibitor momelotinib in the treatment of myelofibrosis.

Related Keywords

Raajit Rampal , Jamile Shammo , , Expert Insights Into , Side Effects , Mpns , Bmpn , Myeloproliferative Neoplasms , Management Of Mpns , Md Anderson Cancer Center , Memorial Sloan Kettering Cancer Center , University Of Kansas Cancer Center , Northwestern University , Basics Of Mpns , Polycythemia Vera , Pv , Bone Marrow Testing , Bone Marrow Changes , Ropeginterferon ,